The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity

COVID-19-specific vaccines are efficient prophylactic weapons against SARS-CoV-2 virus. However, boosting innate responses may represent an innovative way to immediately fight future emerging viral infections or boost vaccines. MV130 is a mucosal immunotherapy, based on a mixture of whole heat-inact...

Descripción completa

Detalles Bibliográficos
Autores principales: del Fresno, Carlos, García-Arriaza, Juan, Martínez-Cano, Sarai, Heras-Murillo, Ignacio, Jarit-Cabanillas, Aitor, Amores-Iniesta, Joaquín, Brandi, Paola, Dunphy, Gillian, Suay-Corredera, Carmen, Pricolo, Maria Rosaria, Vicente, Natalia, López-Perrote, Andrés, Cabezudo, Sofía, González-Corpas, Ana, Llorca, Oscar, Alegre-Cebollada, Jorge, Garaigorta, Urtzi, Gastaminza, Pablo, Esteban, Mariano, Sancho, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637175/
https://www.ncbi.nlm.nih.gov/pubmed/34867974
http://dx.doi.org/10.3389/fimmu.2021.748103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637175/
https://www.ncbi.nlm.nih.gov/pubmed/34867974
http://dx.doi.org/10.3389/fimmu.2021.748103

Ejemplares similares